← Back to Search

Physical and Occupational Therapy for Bone Marrow Transplant Patients

N/A
Recruiting
Led By Sasha Stephen, MD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days after bone marrow transplantation
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether physical and occupational therapy consultation on admission to a bone marrow transplant can reduce complications, length of stay, readmissions, and mortality. Baseline data is used to determine eligibility.

Who is the study for?
This trial is for adults aged 18 or older who are admitted for a bone marrow transplant (BMT) and have not had an inpatient BMT before. It's designed to see if adding physical and occupational therapy right from the start can help reduce complications and improve recovery.
What is being tested?
The study tests whether early consultation with physical and occupational therapists can decrease problems, shorten hospital stays, lower chances of coming back to the hospital within 30 days, and reduce deaths within 90 days after a BMT.
What are the potential side effects?
Since this trial involves non-drug interventions like physical and occupational therapy consultations, typical medication side effects aren't expected. However, there may be general risks associated with any new exercise or therapy regimen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days after bone marrow transplantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days after bone marrow transplantation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
30-day readmission
Secondary study objectives
Acute care length of stay
Complication types and rates
Mortality rates
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: physical and occupational therapyExperimental Treatment1 Intervention
Physical and occupational therapy consultation might be used to provide targeted prehabilitation interventions.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
362 Previous Clinical Trials
91,921 Total Patients Enrolled
Sasha Stephen, MDPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center

Media Library

physical and occupational therapy Clinical Trial Eligibility Overview. Trial Name: NCT05978583 — N/A
physical and occupational therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05978583 — N/A
Bone Marrow Disease Clinical Trial 2023: physical and occupational therapy Highlights & Side Effects. Trial Name: NCT05978583 — N/A
Bone Marrow Disease Research Study Groups: physical and occupational therapy
~26 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top